Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

From COVID to Nicotine Treatments, this Bio Stock is One to Watch

(Image via Lexaria Bioscience Corp.) There’s no shortage of excitement over potential COVID-19 vaccines. Just looking at the response to news around these developments is evidence of that, and one Company is working on a transformative, patented tech...
Stockhouse Editorial | December 1, 2020 |

Should You Buy the Saudi Aramco IPO?

Imagine waking up in your posh high-rise penthouse facing the Red Sea. Above the bustling city hangs a giant artificial moon that livestreams images from outer space. You call for an automated flying taxi, and it carries you to your job genetically modifying humans to m...
Frank Holmes | November 12, 2019 |

Buzz on the Bullboards: Cannabis Tops Health Care

(Image via HEXO Corp.) How high can we get? This past week, it has been the question on the minds of traders, when a market roller coaster saw indexes hit record highs while company earnings saw major names soar and fall in equal measure. Tapping into the larges...
Stockhouse Editorial | June 16, 2021 |

F Disrespectful Fiduciary Responsibility

Concerned under the existential dread that "The robots could take over" and take control of the job of writer as easily as they did to that of the cashier or comedian, I attempted to create an article via an AI algoritm, the result .... There has been a lot of talk in the...
According to published reports | May 6, 2021 |

StableView Tech Podcast with Colin Fisher and Gary Yeoman

In this informative and entertaining podcast, StableView Asset Management President and Portfolio Manager Colin Fisher talks with Chairman and CEO of iLOOKABOUT , Gary Yeoman, about a wide variety topics of in the emerging technology-based real estate sector. iLOOKAB...
Stockhouse Media | September 27, 2019 |

Live from the Floor of VRIC 2020 with Mickey Fulp

Stockhouse Media’s Cindy Broad was joined live at VRIC 2020 by Mickey Fulp: The Mercenary Geologist . Mickey is a Certified Professional Geologist with a B.Sc. Earth Sciences with honor from the University of Tulsa, and M.Sc. Geology from the Universi...
Cindy Broad | February 7, 2020 |

T2 Biosystems Receives BARDA Contract to Fight Antimicrobial Resistance, Shares Up More than 88%

This healthcare diagnostics stock rose more than 88% on Wednesday following the award of a BARDA contract that could be worth up to $69 million. On Wednesday morning, T2 BioSystems Inc. (TTOO:NASDAQ) announced receipt of funding from the U.S. Department of Health a...
Streetwise Reports | September 12, 2019 |

PhaseBio Shares Are on a Tear After Reporting Phase 2a Trial Results

The clinical-stage biopharmaceutical stock surged more than 30% Wednesday following a report that PB2452 caused immediate and sustained reversal of ticagrelor in older and elderly subjects. In a press release issued September 24, PhaseBio Pharmaceuticals Inc. (PHAS...
Streetwise Reports | September 26, 2019 |

Assembly Biosciences Stock Sizzles Following Phase 2a Announcement and Buy Rating from Mizuho

Good news is piling up for this healthcare stock engaged in the treatment of hepatitis B as it trades at 5X its average volume with a 30% stock price gain over previous close. Assembly Biosciences Inc (ASMB:NASDAQ) announced in a press release on October 16, 2019, ...
Streetwise Reports | October 17, 2019 |

June 18th 2020, Silver Chartbook – Make it your own

Make it your own Trading is often compared to professional sports. This not only due to the competitive element. To produce outstanding performance different methodologies are required to reach elevated performance levels. Successful market participation is not achiev...
Korbinian Koller | June 19, 2020 |
1 2 3 4 5 6 7 8 9 10 ...